Hepatitis E Virus Antibodies in Patients with Chronic Liver Disease
Muslim Atiq, Norah J. Shire, Anna Barrett, Susan D. Rouster, Kenneth E. Sherman, and Mohamed T. Shata
Author affiliations: University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA (M. Atiq); University of Cincinnati College of Medicine, Cincinnati, Ohio, USA (N.J. Shire, A. Barrett, S.D. Rouster, K.E. Sherman, M.T. Shata)
Figure 1. Relationship between anti-hepatitis E virus (HEV) immunoglobulin (Ig) G and chronic liver disease. Scattered plot of the optical density (OD) of anti-HEV IgG for both liver disease patients and control groups is shown; each point represents a subject. Means (0.63 and 0.13 for patients with chronic liver disease and for control group, respectively) are plotted as horizontal lines.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.